The Minimum Effective Stack

I've started asking patients to bring in every supplement they take. Not the list they remember — the bottles. Last month a patient's chart said four. The bag she set on my exam table held eleven.

This is a patient I run advanced panels on. Her protocol reflects her genetics, her labs, and two years of longitudinal data. And the stack she spends $300 a month on — the most expensive thing she puts in her body every day — I was tracking with a single question. "Are you still taking those?"

She is. She will be in five years too, unless something changes. Most stacks have no exit. Products enter one at a time — a podcast here, a friend's recommendation there, something a clinician suggested three years ago for a problem that resolved. Nothing leaves, because nothing was ever given a job.

The fix is giving the stack an exit. Also an entrance, and a clock.

Three in four American adults take at least one supplement. Among women over 60 it's eight in ten, and nearly a quarter of adults over 60 take four or more. Longevity patients sit at the far end of every one of those curves — six, ten, fifteen products is a normal Tuesday.

Stanford's nutrition experts made the uncomfortable point in December: most supplements offer no proven benefit for a person eating a balanced diet, and some cause harm.

Read that again, because most people stop at the wrong clause. A person eating a balanced diet. Nobody has one. Your patients live on airplanes, under fluorescent light, on interrupted sleep and 4pm coffee. The gap between what a body needs and what daily life provides is real, and filling it is the whole reason supplements exist. The clinical question is narrower: does this bottle fill a gap this patient actually has?

Because when nobody measures, patients default to one of two places. Blind stacking — product on product, kept because it's already in the cabinet, with only a third of users ever telling a physician what they take and interaction rates in older adults running as high as one in six. Or blanket distrust — one contamination headline and she quietly stops the two things her labs say she needs.

The measured middle is where clinicians earn their keep.

Not "supports energy." A job. This magnesium is for her sleep latency and fasting glucose, and here's where both sit today. This omega-3 is for her triglycerides and hs-CRP. If neither of you can name what a product should move, that tells you something before she spends a dollar.

Two checks guard the entrance. Examine is the evidence filter — independent, sells no products — for what a compound is actually shown to do and at what dose. SuppCo is the quality filter, with independent ratings and a verification arm that buys bottles off the shelf and tests them. What's in the bottle is not always what's on the label.

Then the clock. Every product gets a review date the day it starts. Ninety days is a reasonable default. Forever is not a dose.

Corrective. A measured deficiency with a marker attached. It ends when the marker corrects, and the win is discharging it.

Situational. Vitamin D through the dark months, electrolytes through a training block, extra support through travel or a brutal quarter. Taken when the condition exists, stopped when it doesn't. This is where "take things when you need them" becomes a protocol instead of a vibe.

Experimental. The N of 1 with a declared end date. Something plausible but unproven the patient wants to try? Fine — one variable, one window, one signal.

The quarterly review stops being keep-or-toss. It becomes moving items between shelves and watching the whole thing shrink.

Tracking dies the moment it becomes patient homework. Nobody keeps a supplement diary.

So make the data collect itself. Have the patient connect her SuppCo stack log, or run the protocol through a Fullscript dispensary so ordering history documents what she's actually taking and refilling. Inside Ultralight, the stack sits next to the labs, the wearables, and the notes, so the record shows response over time without anyone transcribing.

The visit changes shape. In my practice, "are you still taking those" has become "here's what moved while you were" — less interrogating adherence, more reading patterns together. Patients buy into plans they can see working.

At the review date, three questions in order. What was this playing for — a marker, a symptom, a gap? Did that signal move inside the window? If not, what would we lose by stopping?

If the answer is "nothing we can name," it retires. Run the exit like an N of 1: hold, re-measure, watch. You're not declaring the molecule useless — you're observing it did nothing measurable for this patient in this window, and absence of signal is a legitimate reason to deprescribe.

The conversation has a ready analogy. If a food you ate daily turned out to be making you sick, you'd stop eating it. A supplement that moves nothing after months is the quieter version of the same discovery, except this one costs $40 a bottle.

Every product retired makes the signal on everything left easier to read.

The eleven-bottle shelf has inertia built in — bottles get finished, and sunk cost keeps products in rotation long after the reason for them expired. Personalized supplement pods flip that physics: the regimen prints in daily packs, the refill cycle becomes a natural review date, and changing the stack costs nothing but a conversation. The most forward practices are packaging it as a program — testing up front (some are piloting epigenetic panels, though the evidence there is too early to hang a clinical claim on), a personalized pod in the middle, a scheduled review on the back end. Selling the living stack, review dates and all, instead of selling bottles and hoping.

The workflow runs on a few tools, each with one job.

Examine is an independent supplement research database that sells no products, and it's my evidence filter. Before I personalize anything, I check what the compound is actually shown to do, at what dose, and where the human evidence goes thin. If Examine says the evidence is weak for the use my patient bought it for, that item starts on the bubble.

SuppCo is the quality filter. It carries independent ratings across more than 160,000 products, plus a verification arm that buys bottles off the shelf and tests them. Examine tells me whether the compound is worth using. SuppCo tells me whether the bottle in front of my patient is what it claims to be.

Ultralight chat is the AI inside my clinical operating system, and it is the per-patient signal layer. I log the reconciled stack, tie each item to its target, and track how the patient responds over time in the record where her labs, wearables, and notes already live. Running the protocol through a Fullscript dispensary helps here too, because the ordering history documents what she is actually taking and refilling, so the tracking collects itself instead of becoming patient homework. Examine and SuppCo tell me what is true in general. Ultralight tells me what is happening with this patient.

Neither one proves a supplement worked. Supplement response is noisy and the evidence is often thin. The tools organize what I need to decide well. The call is mine.

Pick one patient on six or more supplements. Run the three steps on her stack alone.

One patient, one afternoon. You'll find out how much of the stack you've been carrying on faith. And handing someone a shorter list you can both defend is one of the more satisfying conversations of the week.

Be a modern clinician with the help of Ultralight, the AI-native EHR built specifically for functional, integrative, and longevity medicine. We’ve recently launched wearables integrations and improved AI-native clinical workflows - get in touch to see the latest updates.

Running an independent functional or longevity practice takes more than clinical skill. It takes a business model that holds up.

On Wednesday, July 22 at 12:00 PM ET, Sunita Mohanty sits down with Dr. Philip Deibel of D5 Health and Hint Health for a candid conversation on financial sustainability, structuring for growth, and getting admin out of the way so you can focus on care. Register here for free.

A magnesium recall shows the label problem up close. The FDA classified a recall of magnesium glycinate gummies as Class II after the bottles were found to contain undeclared melatonin. A patient taking this for sleep was also getting an unlabeled sleep hormone she never chose. When you reconcile a stack this week, treat the bottle as a claim you still have to verify.

GLP-1 microdosing for "longevity" is outrunning its evidence. Clinics are now prescribing roughly a fifth of the standard dose for healthy-aging goals, and the clinicians doing it openly admit the longevity claims are unproven. Every microdose protocol is off-label by definition. This is the whole issue in one headline. If you cannot name the marker it should move, you cannot say it is working.

AI can now read a patient's voice during a telehealth visit. Canary Speech's new Zoom integration analyzes more than 2,500 acoustic and linguistic features in real time and flags patterns tied to stress, depression, and early cognitive change, often before they surface on a standard screen. Same frame as the rest of this issue: the tool surfaces the signal, you make the call.

Upcoming Conferences & Events

Sept 22–23, MVMNT Longevity Medicine Summit · Coronado, CA · Evidence-graded longevity science, hands-on labs, and clinical frameworks you can implement the week after. Capped at 300 clinicians. Ultralight will be there!

Oct 8–10, A4M Women's Health Summit · San Antonio, TX ·  The best clinical education on hormone, metabolic, and midlife women's health you will see this year. The room to be in if you are growing the perimenopause and menopause side of your practice.

Oct 21–24, NAMS Annual Meeting · San Diego, CA  · The single most practice-changing meeting of the year for midlife women's health. Your protocols will look different after this one.

Nov 5–8, Eudēmonia Summit · West Palm Beach, FL ·  One of the most talked-about longevity gatherings in the U.S. Experientials, hands-on demos, and the best place to try the emerging frameworks your patients will ask you about next year. Ovation and Ultralight will be there!

Nov 5-7, Private Physicians Alliance Annual Meeting · St. Petersburg, FL · The gathering for independent, cash-pay, and concierge physicians navigating practice independence. Practical and peer-driven. Ultralight will be there!

Nov 8-11, American College of Lifestyle Medicine Conference · Orlando, FL · Lifestyle medicine's main annual event — evidence-based approaches to behavior change, chronic disease, and healthspan. Growing overlap with the longevity medicine community.

Dec 11–13, A4M Longevity Fest · Las Vegas, NV  · The biggest longevity event in the U.S. The room spans clinicians, industry, founders, and the people building next year's platforms, and the connections from this one tend to compound through the rest of your year. Ultralight will be there!

Know of an event we should add? Reply and tell us.

The supplement shelf is the last unmeasured frontier in a practice built on measurement. Track it, target it, and cut what does nothing, and care gets cheaper, safer, and easier to defend at the same time.

Reply and tell us the longest stack you cut down this month. The best ideas in this newsletter come from clinicians doing the work.

Until next week, keep building the practice you imagined when you started.

— Dr. G and Sunita